
Nomic Bio
Nomic Bio is a YC Winter 2020 (W20) company. Based in Montreal, QC, Canada. Team of 24.
About Nomic Bio
Summary
Nomic Bio builds a high-throughput protein profiling platform, the nELISA, that lets drug discovery scientists measure hundreds of proteins simultaneously at a fraction of the cost of conventional immunoassays. Its flagship product, Omni 1000, quantifies over 1,000 proteins per sample and replaces the patchwork of legacy ELISA kits that researchers use across discovery, translational, and clinical work. The platform is delivered as a service, consolidating protein measurement from early R&D through to the clinic on a single technology.
Business model
Fee-per-sample service across fixed panels (Omni 1000, Core) and a custom à la carte panel option (Flex)
Go-to-market
High-throughput screening groups at large pharma companies and biotech researchers access the platform through Nomic Bio's service portal, with entry via early-access programs that convert to ongoing sample-submission relationships.
From the Y Combinator listing
Nomic is doing for proteins what Illumina has done for DNA
Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!
Facts
- Healthcare / Healthcare -> Diagnostics
- Montreal, QC, Canada
- 24
- Active
- Growth
Founders (2)
- Jeff Munzar
- Milad Dagher
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works